Susquehanna Fundamental Investments LLC Invests $19.66 Million in Nutrien Ltd. (NYSE:NTR)

Susquehanna Fundamental Investments LLC acquired a new position in shares of Nutrien Ltd. (NYSE:NTR - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 439,400 shares of the company's stock, valued at approximately $19,663,000. Susquehanna Fundamental Investments LLC owned 0.09% of Nutrien as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the company. Nebula Research & Development LLC acquired a new stake in shares of Nutrien during the fourth quarter worth $384,000. Banco Bilbao Vizcaya Argentaria S.A. grew its holdings in Nutrien by 60.7% in the fourth quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 29,893 shares of the company's stock worth $1,322,000 after purchasing an additional 11,287 shares during the period. Kamunting Street Capital Management L.P. grew its holdings in Nutrien by 275.5% in the fourth quarter. Kamunting Street Capital Management L.P. now owns 105,705 shares of the company's stock worth $4,730,000 after purchasing an additional 77,552 shares during the period. J. Safra Sarasin Holding AG grew its holdings in Nutrien by 29.2% in the fourth quarter. J. Safra Sarasin Holding AG now owns 41,153 shares of the company's stock worth $1,840,000 after purchasing an additional 9,313 shares during the period. Finally, MYDA Advisors LLC acquired a new stake in Nutrien in the fourth quarter worth $1,208,000. 63.10% of the stock is currently owned by institutional investors and hedge funds.

Nutrien Price Performance

Shares of NTR stock traded down $0.10 on Thursday, reaching $56.95. The company's stock had a trading volume of 982,427 shares, compared to its average volume of 2,444,124. The company has a quick ratio of 0.82, a current ratio of 1.27 and a debt-to-equity ratio of 0.38. Nutrien Ltd. has a 12-month low of $43.69 and a 12-month high of $60.87. The company has a market capitalization of $27.81 billion, a P/E ratio of 41.57, a PEG ratio of 1.19 and a beta of 0.77. The stock's 50 day simple moving average is $51.34 and its 200-day simple moving average is $49.55.

Nutrien (NYSE:NTR - Get Free Report) last issued its quarterly earnings data on Wednesday, February 19th. The company reported $0.28 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.37 by ($0.09). Nutrien had a return on equity of 6.81% and a net margin of 2.62%. The business had revenue of $5.08 billion during the quarter, compared to analysts' expectations of $5.09 billion. As a group, equities analysts predict that Nutrien Ltd. will post 3.72 earnings per share for the current fiscal year.

Nutrien Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, April 10th. Shareholders of record on Monday, March 31st were given a dividend of $0.545 per share. The ex-dividend date was Monday, March 31st. This represents a $2.18 dividend on an annualized basis and a yield of 3.83%. Nutrien's payout ratio is 159.12%.

Analyst Ratings Changes

NTR has been the subject of a number of research reports. JPMorgan Chase & Co. upgraded shares of Nutrien from an "underweight" rating to a "neutral" rating and raised their price target for the stock from $40.00 to $50.00 in a report on Monday, January 13th. Wells Fargo & Company raised their price objective on shares of Nutrien from $53.00 to $56.00 and gave the company an "equal weight" rating in a research note on Friday, February 21st. Barclays raised their price objective on shares of Nutrien from $56.00 to $59.00 and gave the company an "equal weight" rating in a research note on Wednesday, March 5th. Scotiabank raised their price target on shares of Nutrien from $60.00 to $62.00 and gave the company a "sector outperform" rating in a research report on Monday, February 24th. Finally, UBS Group dropped their price target on shares of Nutrien from $54.00 to $52.00 and set a "neutral" rating on the stock in a research report on Wednesday, April 16th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $59.27.

Nutrien Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.